Significantly, these HCC samples were obtained from patients who had not undergone sorafenib treatment, reinforcing the constitutive expression of NIK/p52/RelB and NRF2 observed in the Huh7-DDX5KO cells (Fig. 7B). Here, RELB is linked to hepatocellular carcinoma.